Skip to main content

Published locations for First-line avelumab/axitinib for RCC benefits wide range of patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. First-line avelumab/axitinib for RCC benefits wide range of patients

User login

  • Reset your password
  • /content/first-line-avelumab/axitinib-rcc-benefits-wide-range-patients
  • /fedprac/article/194886/renal-cell-carcinoma/first-line-avelumab/axitinib-rcc-benefits-wide-range
  • /oncologypractice/article/194886/renal-cell-carcinoma/first-line-avelumab/axitinib-rcc-benefits-wide
  • /fedprac/avaho/article/194886/renal-cell-carcinoma/first-line-avelumab/axitinib-rcc-benefits-wide
  • /hematology-oncology/article/194886/renal-cell-carcinoma/first-line-avelumab/axitinib-rcc-benefits